ENDOMETRIAL CANCER

This early-stage study tested an experimental pill called ATX-559 in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see if the drug could shrink tumors. The study was terminated early, so results …

This study aimed to see if a combination of two drugs, lenvatinib and pembrolizumab, could shrink tumors in Black women whose endometrial cancer had come back. Only 4 people took part before the study was stopped early. The goal was to measure how many patients responded to treat…

This study looked at whether taking the hormone therapy letrozole after standard treatment could help prevent endometrial cancer from coming back in patients with a non-specific molecular profile. The trial planned to include 12 participants but was terminated early, so results a…

This early-stage study tested a new oral drug, NKT3447, in 23 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the best dose. The trial was stopped early, so results are limited.

This early-stage study tested a new drug called PHN-010 in 26 people with advanced lung, colon, endometrial, ovarian, or cervical cancers that had spread. The goal was to check safety and see if the drug could shrink tumors. The study was stopped early, so results are limited.

This study tested a personalized treatment where a patient's own immune cells were genetically modified to recognize and attack unique markers on their cancer. The trial included people with advanced solid tumors like lung, pancreatic, and ovarian cancer who had not responded to …

This study tested a new drug called PRO1107 in 33 people with advanced solid tumors, including ovarian, endometrial, and lung cancers. The goal was to check safety and see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This study tested a combination of two drugs (copanlisib and fulvestrant) in people with advanced endometrial or ovarian cancers that are hormone receptor-positive and have certain gene changes. The goal was to see if the combination was safe and effective. The trial was stopped …

This study looked at 92 women with high-risk endometrial cancer who needed pelvic radiation after surgery. It compared a newer, more precise radiation method (IMRT) with the standard 3D technique to see if it could reduce side effects like bowel and bladder problems. The goal was…